Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Vedanta Biosciences, Inc.

Vedanta Biosciences, Inc.

Stage unknownCambridge, MABiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Mar 1, 2023
    Form D equity offering · $119M (form d sold) · 25 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Vedanta Biosciences, Inc. filed Form D/A: $118,500,000 sold of $118,500,000, Biotechnology”
Investors on record
1 edges
People
4 officers, 8 directors
Timeline
1
  1. Aug 5, 2024
    Vedanta Biosciences, Inc. filed Form D/A: $118,500,000 sold of $118,500,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
14 observations
Every observation on this company